54
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Is social camouflaging associated with anxiety and depression in autistic adults?

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          There is inconsistent evidence for a clear pattern of association between ‘camouflaging’ (strategies used to mask and/or compensate for autism characteristics during social interactions) and mental health.

          Methods

          This study explored the relationship between self-reported camouflaging and generalised anxiety, depression, and social anxiety in a large sample of autistic adults and, for the first time, explored the moderating effect of gender, in an online survey.

          Results

          Overall, camouflaging was associated with greater symptoms of generalised anxiety, depression, and social anxiety, although only to a small extent beyond the contribution of autistic traits and age. Camouflaging more strongly predicted generalised and social anxiety than depression. No interaction between camouflaging and gender was found.

          Limitations

          These results cannot be generalised to autistic people with intellectual disability, or autistic children and young people. The sample did not include sufficient numbers of non-binary people to run separate analyses; therefore, it is possible that camouflaging impacts mental health differently in this population.

          Conclusions

          The findings suggest that camouflaging is a risk factor for mental health problems in autistic adults without intellectual disability, regardless of gender. We also identified levels of camouflaging at which risk of mental health problems is highest, suggesting clinicians should be particularly aware of mental health problems in those who score at or above these levels.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: not found

          A brief measure for assessing generalized anxiety disorder: the GAD-7.

          Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale. The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The PHQ-9: validity of a brief depression severity measure.

            While considerable attention has focused on improving the detection of depression, assessment of severity is also important in guiding treatment decisions. Therefore, we examined the validity of a brief, new measure of depression severity. The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ-9 was completed by 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology clinics. Construct validity was assessed using the 20-item Short-Form General Health Survey, self-reported sick days and clinic visits, and symptom-related difficulty. Criterion validity was assessed against an independent structured mental health professional (MHP) interview in a sample of 580 patients. As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased. Using the MHP reinterview as the criterion standard, a PHQ-9 score > or =10 had a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. Results were similar in the primary care and obstetrics-gynecology samples. In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity. These characteristics plus its brevity make the PHQ-9 a useful clinical and research tool.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The PHQ-9

                Bookmark

                Author and article information

                Contributors
                laura.hull.14@ucl.ac.uk
                lilylevy@live.co.uk
                mengchuan.lai@utoronto.ca
                k.petrides@ucl.ac.uk
                sb205@cam.ac.uk
                cla29@cam.ac.uk
                pls28@medschl.cam.ac.uk
                w.mandy@ucl.ac.uk
                Journal
                Mol Autism
                Mol Autism
                Molecular Autism
                BioMed Central (London )
                2040-2392
                16 February 2021
                16 February 2021
                2021
                : 12
                : 13
                Affiliations
                [1 ]GRID grid.83440.3b, ISNI 0000000121901201, Research Department of Clinical, Educational and Health Psychology, , University College London, ; 1-19 Torrington Place, London, WC1E 7HB UK
                [2 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, Centre for Addiction and Mental Health and The Hospital for Sick Children, Department of Psychiatry, , University of Toronto, ; Toronto, Canada
                [3 ]GRID grid.5335.0, ISNI 0000000121885934, Autism Research Centre, Department of Psychiatry, , University of Cambridge, ; Cambridge, UK
                [4 ]GRID grid.412094.a, ISNI 0000 0004 0572 7815, Department of Psychiatry, , National Taiwan University Hospital and College of Medicine, ; Taipei, Taiwan
                [5 ]GRID grid.83440.3b, ISNI 0000000121901201, London Psychometrics Laboratory, , University College London, ; London, UK
                [6 ]GRID grid.448742.9, ISNI 0000 0004 0422 9435, Present Address: Homerton University Hospital NHS Foundation Trust, ; London, UK
                Author information
                http://orcid.org/0000-0002-8289-2158
                http://orcid.org/0000-0002-9593-5508
                http://orcid.org/0000-0002-7130-8673
                http://orcid.org/0000-0001-9217-2544
                http://orcid.org/0000-0003-2272-2090
                http://orcid.org/0000-0002-3564-5808
                Article
                421
                10.1186/s13229-021-00421-1
                7885456
                33436060
                42e7f70d-cd28-42f9-b035-b38119bcdb23
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 4 November 2020
                : 3 February 2021
                Funding
                Funded by: Medical Research Council (GB)
                Award ID: RG46450
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004440, Wellcome Trust;
                Award ID: RG58828
                Award Recipient :
                Funded by: Innovative Medicines Initiative 2 Joint Undertaking
                Award ID: 777394
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2021

                Neurosciences
                mental health,camouflaging,gender,adults
                Neurosciences
                mental health, camouflaging, gender, adults

                Comments

                Comment on this article